Dr. Katrina Y. Glover, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Southwestern Medical School at Dallas (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 365
Licensed in Texas since 2004, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: University of Texas Southwestern Medical School at Dallas
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
TX license M0091 (first issued 2004; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Mother Frances Hospital Tyler, TX
- Ut Health East Texas Tyler Regional Hospital Tyler, TX
- Ut Health East Texas Athens Hospital Athens, TX
- University of Texas Health Science Center at Tyler Tyler, TX
- Baylor Scott & White Texas Spine & Joint Hospital Tyler, TX
Medical groups
- University of Texas Health Science Center at Tyler-Facilty-Physician (122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 365
- Services billed
- 1,142
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 432 | 158 |
| Established patient office or other outpatient visit, 30-39 minutes | 181 | 104 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 123 | 41 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 88 | 16 |
| New patient office or other outpatient visit, 60-74 minutes | 42 | 42 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 39 | 13 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 34 | 12 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 33 | 25 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 24 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Tyler, TX | 225 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Tyler, TX | 111 |
| Letrozole Other prescribers in Tyler, TX | 86 |
| Gabapentin Other prescribers in Tyler, TX | 67 |
| Potassium Chloride Other prescribers in Tyler, TX | 62 |
| Eliquis (apixaban) Other prescribers in Tyler, TX | 53 |
| Ondansetron Hcl Other prescribers in Tyler, TX | 51 |
| Xarelto (rivaroxaban) Other prescribers in Tyler, TX | 45 |
| Prochlorperazine Maleate Other prescribers in Tyler, TX | 40 |
| Pantoprazole Sodium Other prescribers in Tyler, TX | 33 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 58 payments worth $3,029 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $1,931 |
|---|---|
| AbbVie Inc. | $233 |
| E.r. Squibb & Sons, L.l.c. | $101 |
| Tempus Ai, Inc | $100 |
| GlaxoSmithKline, LLC. | $93.75 |
| Novartis Pharmaceuticals Corporation | $58.35 |
| Array Biopharma Inc | $47.16 |
| Geron Corporation | $44.46 |
| Consulting Fee | $1,675 |
|---|---|
| Food and Beverage | $1,330 |
| Education | $23.10 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP May 22, 2025 | Consulting Fee IMFINZI · Oncology | $1,675 |
| AstraZeneca Pharmaceuticals LP Jun 17, 2025 | Education in-kind Company’s descriptionJournal Article | $23.10 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $30,414 in research payments for these studies, mostly to the institutions running them.
- A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wildtype Recurrent Metastatic Colorectal Cancer Who Have Received Prior Ch…
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.